GlassScriptPhysician profile
Tarun Jain
NPI 1316289077
$11,303.41
in general payments reported to CMS, 2019-2025
35 companies · $598 in 2025
The $598 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $1,392 · 2021: $795 · 2022: $1,121 · 2023: $1,331 · 2024: $5,712 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,698 · Travel and Lodging: $2,307 · Consulting Fee: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,698.42 |
| Travel and Lodging | $2,307.39 |
| Consulting Fee | $1,635.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,331.42 | 2021-2024 | Cardiomems |
| Novartis Pharmaceuticals Corporation | $2,201.01 | 2020-2025 | |
| Abiomed | $1,601.48 | 2020-2025 | Impella |
| Medtronic, INC. | $1,451.07 | 2021-2025 | Hawkone, Corevalve Evolut R, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $570.20 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $417.65 | 2019-2025 | Eliquis, Camzyos |
| Cardiovascular Systems INC. | $343.22 | 2020 | |
| Amgen INC. | $223.35 | 2021-2025 | Repatha |
| Boston Scientific Corporation | $199.35 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.78 | 2020-2024 | Lifevest |
| Chiesi USA, INC. | $165.61 | 2020 | |
| Penumbra, INC. | $144.81 | 2023 | Penumbra System |
| Novo Nordisk INC | $141.58 | 2024 | Wegovy, Ozempic |
| Medtronic Vascular, INC. | $131.17 | 2019 | |
| Alnylam Pharmaceuticals INC. | $130.53 | 2025 | Amvuttra |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surmodics, INC. | $112.65 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Astrazeneca Pharmaceuticals LP | $103.33 | 2020-2022 | |
| Terumo Medical Corporation | $94.19 | 2020 | |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.40 | 2022 | |
| Pfizer INC. | $88.02 | 2020-2025 | |
| Cardiva Medical, INC. | $83.68 | 2020 | |
| Philips North America LLC | $62.76 | 2020 | |
| Cook Medical LLC | $55.55 | 2022-2023 | Advance |
| Abbvie INC. | $48.38 | 2025 | |
| Shockwave Medical, INC | $43.73 | 2020-2021 | |
| Merit Medical Systems INC | $32.90 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.56 | 2023 | Jardiance |
| Edwards Lifesciences Corporation | $30.27 | 2022 | |
| Kestra Medical Technology Services, INC. | $26.53 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $21.56 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $19.35 | 2023 | |
| Merck Sharp & Dohme LLC | $19.01 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $15.41 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $14.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarun Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.